Reperfusion Injury
Recent clinical, regulatory, research and industry developments relating to this disease.
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.
Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke.
Ferroptosis: past, present and future.
NAD<sup>+</sup> homeostasis in renal health and disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 3 clinical trials expected to report results, the earliest in Q1 2027.
- Q1 2027The Use of Peri-Operative Intravenous Estrogen for the Mitigation of Ischemia Reperfusion Injury in the Setting of Renal Transplantation
- Q3 2027Randomized, Single-blind, Multi-center, Placebo-controlled, Phase 2a Clinical Trial of BX-001N to Prevent From Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE)
- Q2 2028A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation
Clinical MilestonesViewHide
- 2026-07-01Randomized, Single-blind, Multi-center, Placebo-controlled, Phase 2a Clinical Trial of BX-001N to Prevent From Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE)Results expected Q3 2027
- 2026-04-23A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney TransplantationResults expected Q2 2028
- 2026-04-16The Use of Peri-Operative Intravenous Estrogen for the Mitigation of Ischemia Reperfusion Injury in the Setting of Renal TransplantationResults expected Q1 2027
- 2026-07-01ClinicalRandomized, Single-blind, Multi-center, Placebo-controlled, Phase 2a Clinical Trial of BX-001N to Prevent From Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE)Results expected Q3 2027
- 2026-04-23ClinicalA Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney TransplantationResults expected Q2 2028
- 2026-04-16ClinicalThe Use of Peri-Operative Intravenous Estrogen for the Mitigation of Ischemia Reperfusion Injury in the Setting of Renal TransplantationResults expected Q1 2027
- 2026-02-01ClinicalEffect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Reperfusion Injury4
- Brain Ischemia2
- Stroke2
- Carcinoma, Renal Cell1
- Cognitive Dysfunction1
- Ischemic Stroke1
- Kidney Diseases1
- Kidney Neoplasms1
Leading journals6
- International journal of molecular sciences2
- Cell death & disease1
- Molecular neurobiology1
- Nature reviews. Nephrology1
- Neuroscience bulletin1
- Signal transduction and targeted therapy1
Leading researchers8
- Battaglia M1
- Cao F1
- Chen Y1
- Crocetto F1
- Deng B1
- Ditonno P1
- Du H1
- Duan H1
Affiliations (unnormalised)6
- Affiliated Drum Tower Hospital1
- Affiliated Qiqihar Hospital1
- Basic medical school1
- Center for Vascular Biology Research and Department of Medicine1
- Clinical Medical College1
- Clinical Municipal Hospital "dr. G. Curteanu" Oradea1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Reperfusion injury is tissue damage that occurs when blood flow is restored after a period of ischemia. The restoration of perfusion can paradoxically worsen functional, metabolic, or structural injury in the affected tissue.
It is caused by reperfusion following ischemia. The grounding supports ischemia-reperfusion as the defining setting, but does not identify additional primary causes beyond the ischemic event and subsequent restoration of blood flow.
The literature grounding links reperfusion injury to multiple injury pathways, including apoptosis, cell death, oxidative stress, inflammatory responses, and neuroinflammation in cerebral ischemia. It also supports involvement of ferroptosis, characterized by iron-dependent lipid peroxidation and reduced antioxidant capacity, as well as signaling networks such as Wnt and complement activation in kidney injury and transplantation settings.
The main risk factor supported by the grounding is prior ischemia followed by reperfusion. The reviewed literature also indicates higher relevance in settings such as ischemic stroke, kidney transplantation, and acute kidney injury, but does not support additional general risk factors.
The grounding supports treatment at the modality and drug-class level only indirectly, mainly through reperfusion-based interventions and investigational neuroprotective or organ-protective strategies. Reported therapeutic areas include thrombolysis and thrombectomy in ischemic stroke, and experimental or clinical attempts targeting neuroinflammation, complement, Wnt-related signaling, ferroptosis, and NAD+ homeostasis. No specific standard drug regimen is supported by the supplied material.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.